SU1217254A3 - Способ получени производных 9-амино-1-оксиоктагидробензо( @ )хинолина или их фармацевтически приемлемых солей - Google Patents

Способ получени производных 9-амино-1-оксиоктагидробензо( @ )хинолина или их фармацевтически приемлемых солей Download PDF

Info

Publication number
SU1217254A3
SU1217254A3 SU813317052A SU3317052A SU1217254A3 SU 1217254 A3 SU1217254 A3 SU 1217254A3 SU 813317052 A SU813317052 A SU 813317052A SU 3317052 A SU3317052 A SU 3317052A SU 1217254 A3 SU1217254 A3 SU 1217254A3
Authority
SU
USSR - Soviet Union
Prior art keywords
hydrogen
carbon atoms
methyl
mixture
alkyl
Prior art date
Application number
SU813317052A
Other languages
English (en)
Russian (ru)
Inventor
Росс Джонсон Майкл
Original Assignee
Пфайзер Инк (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Инк (Фирма) filed Critical Пфайзер Инк (Фирма)
Application granted granted Critical
Publication of SU1217254A3 publication Critical patent/SU1217254A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C07D221/12—Phenanthridines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
SU813317052A 1980-07-28 1981-07-22 Способ получени производных 9-амино-1-оксиоктагидробензо( @ )хинолина или их фармацевтически приемлемых солей SU1217254A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/173,207 US4309545A (en) 1980-07-28 1980-07-28 Oximino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof

Publications (1)

Publication Number Publication Date
SU1217254A3 true SU1217254A3 (ru) 1986-03-07

Family

ID=22630983

Family Applications (1)

Application Number Title Priority Date Filing Date
SU813317052A SU1217254A3 (ru) 1980-07-28 1981-07-22 Способ получени производных 9-амино-1-оксиоктагидробензо( @ )хинолина или их фармацевтически приемлемых солей

Country Status (29)

Country Link
US (1) US4309545A (enExample)
EP (1) EP0045171B1 (enExample)
JP (1) JPS57112372A (enExample)
KR (1) KR850000273B1 (enExample)
AR (1) AR230988A1 (enExample)
AT (1) ATE11775T1 (enExample)
AU (1) AU525944B2 (enExample)
CA (1) CA1178274A (enExample)
CS (1) CS228515B2 (enExample)
DD (1) DD202012A5 (enExample)
DE (1) DE3168891D1 (enExample)
DK (1) DK334581A (enExample)
EG (1) EG15535A (enExample)
ES (1) ES8301926A1 (enExample)
FI (1) FI812338A7 (enExample)
GR (1) GR75283B (enExample)
GT (1) GT198170557A (enExample)
HU (1) HU185133B (enExample)
IE (1) IE51426B1 (enExample)
IL (1) IL63423A0 (enExample)
IN (1) IN158867B (enExample)
NO (2) NO812557L (enExample)
NZ (1) NZ197856A (enExample)
PH (1) PH17281A (enExample)
PL (1) PL133928B1 (enExample)
PT (1) PT73440B (enExample)
SU (1) SU1217254A3 (enExample)
YU (1) YU185181A (enExample)
ZA (1) ZA815128B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920221A (en) * 1982-03-16 1990-04-24 Pfizer Inc. Substituted decahydro-1H-pyrido[1,2-f]phenanthridines and decahydropyrrolo[1,2-f]phenanthridines
US4642373A (en) * 1982-03-16 1987-02-10 Pfizer Inc. Substituted dodecahydrotripheylenes, and decahydropyrrolo[1,2-f]phenanthridines as CNS agents
US4473704A (en) * 1982-03-16 1984-09-25 Pfizer Inc. Substituted dodecahydrotriphenylenes, decahydro-1H-cyclopenta[1]phenanthrenes, decahydro-1H-pyrido[1,2-f]phenanthridines and decahydropyrrolo[1,2-f]phenanthridines as CNS agents
US5605906A (en) * 1995-03-24 1997-02-25 Merck Frosst Canada, Inc. Cannabinoid receptor agonists
KR100454781B1 (ko) * 1996-01-31 2005-04-08 알타나 파마 아게 신규한페난트리딘
US6127378A (en) * 1996-03-26 2000-10-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridines substituted in the 6 position
EP0889886B1 (de) * 1996-03-26 2002-09-18 ALTANA Pharma AG Neue in 6-position substituierte phenanthridine
US5776482A (en) * 1996-03-29 1998-07-07 University Of Iowa Research Foundation Tetrahydroquinoline analogues for use in glaucoma treatment
ATE224372T1 (de) * 1997-07-25 2002-10-15 Altana Pharma Ag Substituierte 6-alkylphenanthridine
US6121279A (en) * 1997-07-25 2000-09-19 Byk Gulden Lomberg Chemische Fabrik Gmbh Substituted 6-phenylphenanthridines
AU3910700A (en) 1999-03-22 2000-10-09 Immugen Pharmaceuticals, Inc. Treatment of immune diseases
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
US20060084021A1 (en) * 2004-09-10 2006-04-20 Kubicek Chris A Wick holder
WO2002026728A2 (en) * 2000-09-28 2002-04-04 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
WO2002026224A2 (en) * 2000-09-28 2002-04-04 Immugen Pharmaceuticals, Inc. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
WO2003080043A1 (en) * 2002-03-18 2003-10-02 Immugen Pharmaceuticals, Inc. Topical formulations of resorcinols and cannibinoids and methods of use
AU2005247480A1 (en) * 2004-05-25 2005-12-08 Qlt Inc. Oculoselective drugs and prodrugs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839441A (en) * 1969-10-27 1974-10-01 Hoffmann La Roche Intermediates for partially hydrogenated phenanthridines
US3878219A (en) * 1973-07-13 1975-04-15 Abbott Lab 5H-{8 1{9 benzopyrano{8 3,4-d{9 pyridines
US3928598A (en) * 1973-11-05 1975-12-23 Lilly Co Eli Hexahydro-dibenzo{8 b,d{9 pyran-9-ones as an anti-anxiety drug
US4087545A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs
HU180916B (hu) 1976-05-17 1983-05-30 Pfizer Eljárás benzo[c]kinolin-származékok előállítására
SE7704749L (sv) * 1976-05-17 1977-12-05 Pfizer Kinoliner och forfarande och mellanprodukter for framstellning derav
US4152450A (en) * 1978-02-17 1979-05-01 Eli Lilly And Company 9-Amino-dibenzopyrans

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Бюлер К., Пирсон Д. Органические синтезы, ч. 1, - М.: Мир, 1973, с. 482. *

Also Published As

Publication number Publication date
JPS57112372A (en) 1982-07-13
IE51426B1 (en) 1986-12-24
FI812338L (fi) 1982-01-29
CS228515B2 (en) 1984-05-14
AR230988A1 (es) 1984-08-31
DE3168891D1 (en) 1985-03-28
AU525944B2 (en) 1982-12-09
KR830006217A (ko) 1983-09-20
PH17281A (en) 1984-07-06
NO812557L (no) 1982-01-29
NO854454L (no) 1985-01-29
PL133928B1 (en) 1985-07-31
HU185133B (en) 1984-12-28
AU7343481A (en) 1982-05-06
IE811686L (en) 1982-01-28
NZ197856A (en) 1984-10-19
YU185181A (en) 1983-12-31
EP0045171A3 (en) 1982-04-28
GR75283B (enExample) 1984-07-13
EP0045171A2 (en) 1982-02-03
EP0045171B1 (en) 1985-02-13
KR850000273B1 (ko) 1985-03-15
ZA815128B (en) 1982-07-28
PT73440B (en) 1983-06-20
ES504323A0 (es) 1982-12-16
GT198170557A (es) 1983-01-12
IL63423A0 (en) 1981-10-30
PT73440A (en) 1981-08-01
PL232331A1 (en) 1983-09-26
CA1178274A (en) 1984-11-20
FI812338A7 (fi) 1982-01-29
DK334581A (da) 1982-01-29
US4309545A (en) 1982-01-05
EG15535A (en) 1986-09-30
ES8301926A1 (es) 1982-12-16
DD202012A5 (de) 1983-08-24
ATE11775T1 (de) 1985-02-15
IN158867B (enExample) 1987-02-07

Similar Documents

Publication Publication Date Title
SU1217254A3 (ru) Способ получени производных 9-амино-1-оксиоктагидробензо( @ )хинолина или их фармацевтически приемлемых солей
US3262977A (en) N-aralkyl-1, 1-diphenyl-propylamine derivatives
PL201683B1 (pl) Pochodne pirydopiranoazepiny, sposób ich wytwarzania i środek farmaceutyczny
SU1750417A3 (ru) Способ получени (S)-норфлуоксетина, или его фармацевтически приемлемых солей, или их гидратов
WO1990012574A1 (en) Dopamine agonist compounds
RS54309B1 (sr) Dihidroetorfini i njihovo pripremanje
US4132709A (en) [2]Benzopyrano[4,3-c]pyridine derivatives and process therefor
Anderson et al. Synthesis and pharmacological evaluation of sulfonium analogs of dopamine: nonclassical dopamine agonists
JPH06293761A (ja) スピロ橋かけ型および非橋かけ型複素環式化合物
CA1250582A (en) Tetrahydrocorynantheine derivatives and process for their preparation
FI88162B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara sulfonyldekahydro-8h-isokino/2,1-g//1,6/naftyridiner, deras optiska isomerer samt farmaceutiskt godtagbara salter
KOJIMA et al. Syntheses of (±)-2-[(inden-7-yloxy) methyl] morpholine hydrochloride (YM-08054, indeloxazine hydrochloride) and its derivatives with potential cerebral-activating and antidepressive properties
DD211559A5 (de) Verfahren zur herstellung bicyclischer, benzokondensierter verbindungen
US3998843A (en) Quaternary ammonium compounds
DD219765A5 (de) Verfahren zur herstellung von substituierten hexahydropyrrolo (-1,2-a)-chinolin-, hexahydro-1h-pyrido (1,2-a)chinolin-, hexahydrobenzo(e)inden- und octahydrophenanthren-zns-mitteln
EP0538477B1 (en) Novel cyclic aminophenylacetic acid derivative, production thereof, and immune response modulator containing the same as active ingredient
SU1731052A3 (ru) Способ получени фенотиазиновых соединений, или их сложных низших алкиловых эфиров, или их фармацевтически приемлемых кислотно-аддитивных солей
DE2722383C2 (enExample)
JPH0227969B2 (enExample)
KR960014352B1 (ko) 치환된 테트라하이드로이소퀴놀린 화합물, 이의 제조방법 및 이를 함유하는 약제학적 조성물
CH634311A5 (fr) Derives du benzo(d)thiazole, leur procede de preparation et leurs applications en therapeutique.
WO2003004026A1 (de) Substituierte 1-phenethylpiperidinverbindungen, die unter anderem als analgetika verwendung finden
IE57548B1 (en) Tetrahydroisoxazolo(4,5-c)pyridine derivatives and preparation thereof
NZ231243A (en) Diphenylalkylamide derivatives and pharmaceutical compositions thereof
CN111417637B (zh) 抗疼痛化合物及其制备方法